Compound Evidence File
#EC-2026-0011
PE 22-28
Filed under Peptides. The bureau holds 212 laboratory returns for this compound from 86 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
86 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 6 | 10.0 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| Shanghai ERP BiotechnologyCASE #VI-2026-0936 | A | 4 | 10.0 | 10.0 | 10.0 | 3 May 2026 | 1 Jul 2026 |
| Kerui PeptidesCASE #VI-2026-0626 | A | 4 | 10.0 | 9.9 | 10.0 | 25 Feb 2026 | 1 Jun 2026 |
| Shanghai Wibson BiotechnologyCASE #VI-2026-0379 | A | 4 | 10.0 | 10.0 | 10.0 | 3 Nov 2025 | 8 Jun 2026 |
| GenScript PeptidesCASE #VI-2026-0860 | A | 4 | 10.0 | 10.0 | 10.0 | 7 Jul 2026 | 26 Jul 2026 |
| Chinese Peptide CompanyCASE #VI-2026-0184 | A | 3 | 10.0 | 9.9 | 10.0 | 3 Mar 2026 | 3 Jun 2026 |
| WuXi TIDESCASE #VI-2026-0335 | A | 3 | 10.0 | 9.9 | 10.0 | 8 Mar 2026 | 18 Jun 2026 |
| AmbioPharmCASE #VI-2026-0177 | A | 3 | 10.0 | 9.9 | 10.0 | 22 Apr 2026 | 2 Aug 2026 |
| QYAOBIOCASE #VI-2026-0861 | A | 2 | 10.0 | 10.0 | 10.0 | 14 Mar 2026 | 22 May 2026 |
| Sigma-AldrichCASE #VI-2026-0829 | A | 2 | 10.0 | 10.0 | 10.0 | 10 Feb 2026 | 13 Aug 2026 |
| CellupepCASE #VI-2026-0888 | X | 1 | 10.0 | 10.0 | 10.0 | 2 Apr 2025 | 2 Apr 2025 |
| HomopeptideCASE #VI-2026-0760 | A | 4 | 9.9 | 9.9 | 10.0 | 24 May 2026 | 24 May 2026 |
| BachemCASE #VI-2026-0314 | A | 4 | 9.9 | 9.9 | 10.0 | 9 Nov 2025 | 9 Jul 2026 |
| Mokemei BiotechnologyCASE #VI-2026-0540 | A | 4 | 9.9 | 9.9 | 10.0 | 9 Apr 2026 | 24 Jun 2026 |
| PolyPeptide GroupCASE #VI-2026-0143 | A | 4 | 9.9 | 9.9 | 10.0 | 3 Apr 2026 | 27 Jun 2026 |
| SinoPepCASE #VI-2026-0387 | A | 4 | 9.9 | 9.9 | 10.0 | 2 Feb 2026 | 2 Aug 2026 |
| Hubei JianxiangCASE #VI-2026-0048 | A | 3 | 9.9 | 9.9 | 9.9 | 24 Nov 2025 | 27 Jun 2026 |
| Shanghai Sigma AudleyCASE #VI-2026-0505 | A | 3 | 9.9 | 9.9 | 10.0 | 3 Jan 2026 | 9 Jun 2026 |
| Thermo Fisher ScientificCASE #VI-2026-0142 | A | 3 | 9.9 | 9.9 | 10.0 | 26 Jan 2026 | 15 Jun 2026 |
| Sangon BioCASE #VI-2026-0671 | A | 2 | 9.9 | 9.9 | 10.0 | 14 May 2026 | 27 May 2026 |
| JEEP PeptidesCASE #VI-2026-0457 | A | 2 | 9.9 | 9.9 | 9.9 | 3 May 2026 | 6 Jul 2026 |
| Flourishglobal PeptideCASE #VI-2026-0630 | A | 2 | 9.9 | 9.9 | 9.9 | 12 May 2026 | 23 May 2026 |
| Hybio PharmaceuticalCASE #VI-2026-0065 | A | 2 | 9.9 | 9.9 | 9.9 | 16 Jan 2026 | 1 Aug 2026 |
| AsymchemCASE #VI-2026-0091 | A | 2 | 9.9 | 9.9 | 10.0 | 9 May 2026 | 19 May 2026 |
| Hunan GoodPeptides Biotech CoCASE #VI-2026-0370 | X | 1 | 9.6 | 9.6 | 9.6 | 9 Jun 2025 | 9 Jun 2025 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 4 | 9.2 | 8.5 | 9.8 | 24 May 2026 | 24 May 2026 |
| Accelerate LabsCASE #VI-2026-0686 | X | 2 | 9.2 | 8.7 | 9.7 | 28 Mar 2025 | 21 May 2026 |
| Peptronix Bio PTBCASE #VI-2026-0979 | X | 1 | 9.2 | 9.2 | 9.2 | 21 May 2025 | 21 May 2025 |
| Peptide HavenCASE #VI-2026-0898 | X | 1 | 9.1 | 9.1 | 9.1 | 13 Feb 2025 | 13 Feb 2025 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 5 | 8.7 | 6.1 | 10.0 | 24 May 2026 | 24 May 2026 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 4 | 8.7 | 8.3 | 9.1 | 24 May 2026 | 24 May 2026 |
| Platinum CryoCASE #VI-2026-0406 | X | 1 | 8.7 | 8.7 | 8.7 | 25 Apr 2025 | 25 Apr 2025 |
| PurePeptidesCASE #VI-2026-0234 | X | 1 | 8.7 | 8.7 | 8.7 | 11 Jun 2025 | 11 Jun 2025 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 5 | 8.6 | 7.3 | 10.0 | 24 May 2026 | 24 May 2026 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 7 | 8.3 | 7.2 | 9.8 | 21 May 2026 | 21 May 2026 |
| Tianjin Ruiwang New Material Technology CoCASE #VI-2026-0192 | X | 6 | 8.3 | 6.8 | 10.0 | 3 Jun 2025 | 23 May 2026 |
| Mai PeptideCASE #VI-2026-0769 | X | 1 | 7.9 | 7.9 | 7.9 | 3 Jul 2025 | 3 Jul 2025 |
| HK PeptidesCASE #VI-2026-0140 | X | 11 | 7.7 | 6.3 | 9.7 | 3 Jun 2025 | 24 May 2026 |
| Nanjing Xiyuxun Technology XYXCASE #VI-2026-0433 | X | 1 | 7.6 | 7.6 | 7.6 | 2 Jul 2025 | 2 Jul 2025 |
| EHZ PeptidesCASE #VI-2026-0296 | C | 3 | 7.5 | 5.9 | 9.5 | 9 Jun 2025 | 17 May 2026 |
| TCICASE #VI-2026-0650 | X | 1 | 7.5 | 7.5 | 7.5 | 24 Apr 2025 | 24 Apr 2025 |
| Skye PeptidesCASE #VI-2026-0451 | X | 5 | 7.4 | 5.1 | 8.7 | 7 May 2025 | 21 May 2026 |
| Chimera PeptidesCASE #VI-2026-0260 | X | 1 | 7.4 | 7.4 | 7.4 | 2 Jul 2025 | 2 Jul 2025 |
| Peptide CraftersCASE #VI-2026-0994 | X | 2 | 7.2 | 5.7 | 8.6 | 3 Jun 2025 | 23 May 2026 |
| Reta-PeptideCASE #VI-2026-0756 | X | 7 | 7.1 | 4.4 | 8.8 | 8 Jul 2025 | 24 May 2026 |
| SRY LabsCASE #VI-2026-0657 | X | 5 | 7.1 | 4.7 | 8.3 | 9 Jun 2025 | 24 May 2026 |
| NexaphCASE #VI-2026-0944 | X | 8 | 7.0 | 5.6 | 10.0 | 2 Apr 2025 | 25 May 2026 |
| Xian Yihang TechnologyCASE #VI-2026-0656 | X | 3 | 7.0 | 6.4 | 7.5 | 3 Jul 2025 | 17 May 2026 |
| Glamgurcraft Innovations Foreign TradeCASE #VI-2026-0348 | X | 1 | 6.9 | 6.9 | 6.9 | 24 Apr 2025 | 24 Apr 2025 |
| Peptide PartnersCASE #VI-2026-0295 | X | 2 | 6.8 | 6.2 | 7.3 | 14 Jan 2025 | 24 May 2026 |
| UWA Elite PeptidesCASE #VI-2026-0130 | X | 1 | 6.8 | 6.8 | 6.8 | 20 Jun 2025 | 20 Jun 2025 |
| Hangzhou Mandy BiotechnologyCASE #VI-2026-0695 | X | 1 | 6.7 | 6.7 | 6.7 | 3 Jun 2025 | 3 Jun 2025 |
| Haikou Mingheng TechnologyCASE #VI-2026-0250 | X | 1 | 6.7 | 6.7 | 6.7 | 3 Jun 2025 | 3 Jun 2025 |
| HazelCASE #VI-2026-0392 | X | 1 | 6.7 | 6.7 | 6.7 | 3 Jun 2025 | 3 Jun 2025 |
| LipeptidesCASE #VI-2026-0863 | X | 1 | 6.6 | 6.6 | 6.6 | 2 Apr 2025 | 2 Apr 2025 |
| Rayshine Peptide BiochemicalsCASE #VI-2026-0545 | X | 1 | 6.5 | 6.5 | 6.5 | 28 Mar 2025 | 28 Mar 2025 |
| Hangzhou Youngpeptide Biotechnology HYBCASE #VI-2026-0347 | X | 1 | 6.5 | 6.5 | 6.5 | 24 Apr 2025 | 24 Apr 2025 |
| Champion PeptideCASE #VI-2026-0909 | X | 1 | 6.5 | 6.5 | 6.5 | 8 Jul 2025 | 8 Jul 2025 |
| YimeiCASE #VI-2026-0081 | X | 5 | 6.4 | 4.9 | 9.7 | 13 Jun 2025 | 24 May 2026 |
| Mix PeptidesCASE #VI-2026-0699 | X | 1 | 6.4 | 6.4 | 6.4 | 3 Jul 2025 | 3 Jul 2025 |
| Shanxi Qianyecao Biotech QYCCASE #VI-2026-0189 | X | 4 | 6.3 | 5.1 | 7.3 | 7 May 2025 | 26 Jan 2026 |
| Zenith Jove Peptide ZJCASE #VI-2026-0570 | X | 2 | 6.3 | 5.7 | 6.9 | 6 May 2025 | 20 May 2026 |
| Forever Young PharmacyCASE #VI-2026-0654 | X | 1 | 6.3 | 6.3 | 6.3 | 13 Feb 2025 | 13 Feb 2025 |
| ScienceCASE #VI-2026-0636 | X | 1 | 6.2 | 6.2 | 6.2 | 3 Jun 2025 | 3 Jun 2025 |
| Evolve BioPepCASE #VI-2026-0755 | X | 1 | 6.1 | 6.1 | 6.1 | 14 Jan 2025 | 14 Jan 2025 |
| Shenzhen Loga Tech LG LOGACASE #VI-2026-0920 | X | 2 | 6.0 | 5.6 | 6.4 | 2 Jul 2025 | 19 Jan 2026 |
| Prime PeptidesCASE #VI-2026-0696 | X | 1 | 5.9 | 5.9 | 5.9 | 20 Jun 2025 | 20 Jun 2025 |
| Suaway Lab ResearchCASE #VI-2026-0488 | X | 3 | 5.6 | 4.9 | 7.0 | 21 May 2025 | 21 May 2026 |
| Hebei Rimao TechnologyCASE #VI-2026-0529 | X | 1 | 5.5 | 5.5 | 5.5 | 25 Apr 2025 | 25 Apr 2025 |
| Hunan Ruiwang Technology CenterCASE #VI-2026-0027 | X | 1 | 5.4 | 5.4 | 5.4 | 2 Apr 2025 | 2 Apr 2025 |
| Biolabshop LimitedCASE #VI-2026-0832 | X | 1 | 5.3 | 5.3 | 5.3 | 11 Jun 2025 | 11 Jun 2025 |
| Alimo PeptideCASE #VI-2026-0524 | X | 1 | 5.1 | 5.1 | 5.1 | 2 Jul 2025 | 2 Jul 2025 |
| Precision Peptide CoCASE #VI-2026-0559 | X | 1 | 4.9 | 4.9 | 4.9 | 2 Jul 2025 | 2 Jul 2025 |
| Oasis PeptidesCASE #VI-2026-0404 | X | 1 | 4.8 | 4.8 | 4.8 | 3 Jun 2025 | 3 Jun 2025 |
| Shanghai OuDaXin New Material Technology CenterCASE #VI-2026-0498 | X | 1 | 4.5 | 4.5 | 4.5 | 28 Mar 2025 | 28 Mar 2025 |
| YB PeptideCASE #VI-2026-0813 | X | 1 | 4.5 | 4.5 | 4.5 | 25 Apr 2025 | 25 Apr 2025 |
| DeuschemCASE #VI-2026-0004 | X | 2 | 4.2 | 4.2 | 4.3 | 11 Jun 2025 | 21 May 2026 |
| WllyBIOCASE #VI-2026-0470 | X | 1 | 3.8 | 3.8 | 3.8 | 8 Jul 2025 | 8 Jul 2025 |
| Liberty PeptidesCASE #VI-2026-0416 | X | 1 | 3.2 | 3.2 | 3.2 | 2 Jul 2025 | 2 Jul 2025 |
| Lejian Biotech PeptideCASE #VI-2026-0746 | X | 1 | 1.5 | 1.5 | 1.5 | 2 Apr 2025 | 2 Apr 2025 |
| Advanced Technology and IndustrialCASE #VI-2026-0133 | X | 1 | 1.3 | 1.3 | 1.3 | 21 May 2025 | 21 May 2025 |
| HK Fat CatCASE #VI-2026-0376 | X | 1 | 0.8 | 0.8 | 0.8 | 13 Feb 2025 | 13 Feb 2025 |
| Explicit SarmsCASE #VI-2026-0017 | X | 1 | 0.2 | 0.2 | 0.2 | 24 Apr 2025 | 24 Apr 2025 |
| PRIVATECASE #VI-2026-0635 | X | 1 | 0.2 | 0.2 | 0.2 | 3 Jun 2025 | 3 Jun 2025 |
| Guangzhou Yuao TradingCASE #VI-2026-0787 | X | 1 | 0.0 | 0.0 | 0.0 | 25 Apr 2025 | 25 Apr 2025 |
| Wuhan Newtop BiotechCASE #VI-2026-0676 | X | 1 | 0.0 | 0.0 | 0.0 | 27 Feb 2025 | 27 Feb 2025 |
Open any subject to view the batch-level evidence for PE 22-28 alone.